-
Product Insights
NewLikelihood of Approval Analysis for Peanut Allergy
Overview How likely is it that the drugs in Peanut Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peanut Allergy Overview Peanut allergy is common, especially in children. An allergic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allergen For Peanut Allergy in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allergen For Peanut Allergy in Peanut Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergen For Peanut Allergy in Peanut Allergy Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Remibrutinib in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Remibrutinib in Peanut Allergy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Remibrutinib in Peanut Allergy Drug Details: LOU-064 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CA-002 in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CA-002 in Peanut Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CA-002 in Peanut Allergy Drug Details: CA-002 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acalabrutinib Maleate in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acalabrutinib Maleate in Peanut Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acalabrutinib Maleate in Peanut Allergy Drug Details: Acalabrutinib maleate (Calquence) is...
-
Product Insights
Peanut Allergy – Drugs In Development, 2023
Global Markets Direct’s, ‘Peanut Allergy - Drugs In Development, 2023’, provides an overview of the Peanut Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peanut Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Omalizumab in Peanut Allergy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Omalizumab in Peanut Allergy Drug Details: Omalizumab (Xolair, Bolstran) is a recombinant DNA-derived humanized IgG1-kappa...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allergen For Peanut Allergy in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allergen For Peanut Allergy in Peanut Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Allergen For Peanut Allergy in Peanut Allergy Drug Details:Allergen is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INT-301 in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INT-301 in Peanut Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INT-301 in Peanut Allergy Drug Details: INT-301 is under development for the...
-
Product Insights
NewLikelihood of Approval Analysis for Food Allergy
Overview How likely is it that the drugs in Food Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Food Allergy Overview Food allergies are immune system reactions to certain proteins...